TABLE 3

Diagnostic Performance of PET Using 18F-FDG

IndexAll studies (n = 10)Studies with low prevalence (≤15%) of PALN metastasis (n = 5)Studies with high prevalence (>15%) of PALN metastasis (n = 5)
Sensitivity0.34 (0.10–0.72)0.05 (0–0.55)0.73 (0.53–0.87)
Specificity0.97 (0.93–0.99)0.99 (0.90–1.00)0.93 (0.86–0.97)
Positive LR12.49 (4.64–33.62)9.15 (0.37–226.46)10.62 (4.90–23.05)
Negative LR0.68 (0.40–1.15)0.95 (0.82–1.11)0.29 (0.15–0.55)
Diagnostic odds ratio18.49 (4.72–72.43)9.60 (0.35–261.70)36.80 (11.03–122.76)
  • Data in parentheses are 95% CIs.